Micro Labs Limited secured FDA approval for its Tramadol Hydrochloride and Acetaminophen oral tablet formulation, expanding its product portfolio in the U.S. pain management market. This regulatory milestone is anticipated to bolster the manufacturer's revenue streams through increased generic sales within the acute pain sector.